Author

Mark N. Levine

National Institutes of HealthORCID 0000-0003-1288-0773Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Cancer Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Assay:bulk RNA-seq· 1 Research Focus:drug response / drug discovery· 1 Approach:experimental assay· 1 Organism:human· 1

Frequent Co-Authors

Daniel R. CrooksiD· 1 shared Jeffrey R BrenderiD· 1 shared Kazutoshi YamamotoiD· 1 shared Murali Cherukuri KrishnaiD· 1 shared Shun KishimotoiD· 1 shared William Marston LinehaniD· 1 shared Yamashita Kota· 1 shared Yasunori OtowaiD· 1 shared

Activity by Year

2024-2024 · peak 1/yr

Co-Author Collaboration Network

8 top collaborators · 28 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCancer Biology

Daniel R. CrooksORCID

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

Cancer BiologyFree Radical Biology and MedicinePeer-reviewedMay 15, 2024

Pharmacological Ascorbate Induces Transient Hypoxia Sensitizing Pancreatic Ductal Adenocarcinoma to a Hypoxia Activated Prodrug

Shun Kishimoto, Daniel R. Crooks, Yasunori Otowa…·Jeffrey R Brender

This study shows that pharmacological ascorbate induces transient hypoxia in pancreatic ductal adenocarcinoma, enhancing the efficacy of the hypoxia-activated prodrug evofosfamide in some tumor models.

1 citation

humanbulk RNA-seq

𝕏 PostBluesky